Nervous System Disorders of Nonhuman Primates and Research Models

Nonhuman Primates in Biomedical Research: Diseases: Second Edition

Volumn 2, Issue , 2012, Pages 733-782

  Fahey, Michele A ^a   Westmoreland, Susan V ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882541352     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-381366-4.00015-8     Document Type: Chapter

References (532)

1. Abbott D.P., Edmondson N.A. Neuronal ceroid-lipofuscin storage in a cynomolgus monkey (Macaca fascicularis). Lab. Anim 1983, 17:18-20.
2. Achim C.L., Masliah E., et al. Macrophage activation factors in the brains of AIDS patients. J. Neuro. AIDS 1996, 1:1-16.
3. Achim C.L., Wiley C.A. Inflammation in AIDS and the role of the macrophage in brain pathology. Curr. Opin. Neurol 1996, 9:221-225.
4. Adamson D.C., Dawson T.M., et al. Neurovirulent simian immunodeficiency virus infection induces neuronal, endothelial, and glial apoptosis. Mol. Med 1996, 2:417-428.
5. Adle-Biassette H., Levy Y., et al. Neuronal apoptosis in HIV infection in adults. Neuropathol. Appl. Neurobiol 1995, 21:218-227.
6. Agamanolis D.P., Chester E.M., et al. Neuropathology of experimental vitamin B12 deficiency in monkeys. Neurology 1976, 26:905-914.
7. Albin R.L., Tagle D.A. Genetics and molecular biology of Huntington's disease. Trends Neurosci 1995, 18:11-14.
8. Albrecht P., Burnstein T., et al. Subacute sclerosing panencephalitis: Experimental infection in primates. Science 1977, 195:64-66.
9. Albrecht P., Lorenz D., et al. Encephalitogenicity of measles virus in marmosets. Infect. Immun 1981, 34:581-587.
10. Albrecht P., Lorenz D., et al. Fatal measles infection in marmosets pathogenesis and prophylaxis. Infect. Immun 1980, 27:969-978.
11. Ali I., Tubbs J., et al. Evaluation of the setup accuracy of a stereotactic radiotherapy head immobilization mask system using kV on-board imaging. J. Appl. Clin. Med. Phys 2011, 11:3192.
12. Alirezaei M., Watry D.D., et al. Human immunodeficiency virus-1/surface glycoprotein 120 induces apoptosis through RNA-activated protein kinase signaling in neurons. J. Neurosci 2007, 27:11047-11055.
13. Allam M.F., Del Castillo A.S., et al. Parkinson's disease risk factors: Genetic, environmental, or both?. Neurol. Res 2005, 27:206-208.
14. Allmond B.W., Froeschle J.E., et al. Paralytic poliomyelitis in large laboratory primates. Virologic investigation and report on the use of oral poliomeylitis virus (OPV) vaccine. Am. J. Epidemiol 1967, 85:229-239.
15. Anderon D., McClure H.D. Toxoplasmosis. Monographs on Pathology of Laboratory Animals: Nonhuman Primates 1993, Vol. 1. Springer-Verlag, New York, NY. T.C. Jones, U. Mohr, R.D. Hunt (Eds.).
16. Anderson D.C., McClure H.M. Acute disseminated fatal toxoplasmosis in a squirrel monkey. J. Am. Vet. Med. Assoc 1982, 181:1363-1366.
17. Anderson E., Zink W., et al. HIV-1-associated dementia: A metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes. J. Acquir. Immune. Defic. Syndr 2002, 31(Suppl. 2):S43-S54.
18. Anderson E.R., Gendelman H.E., et al. Memantine protects hippocampal neuronal function in murine human immunodeficiency virus type 1 encephalitis. J. Neurosci 2004, 24:7194-7198.
19. Ang K.K., Jiang G.L., et al. Extent and kinetics of recovery of occult spinal cord injury. Int. J. Radiat. Oncol. Biol. Phys 2001, 50:1013-1020.
20. Annamalai L., Bhaskar V., et al. Impact of short-term combined antiretroviral therapy on brain virus burden in simian immunodeficiency virus-infected and CD8+ lymphocyte-depleted rhesus macaques. Am. J. Pathol 2010.
21. Anver M.R., King N.W., et al. Congenital encephalitozoonosis in a squirrel monkey (Saimiri sciureus). Vet. Pathol 1972, 9:475-480.
22. Axthelm M.K., Koralnik I.J., et al. Meningoencephalitis and demyelination are pathologic manifestations of primary polyomavirus infection in immunosuppressed rhesus monkeys. J. Neuropathol. Exp. Neurol 2004, 63:750-758.
23. Babas T., Dewitt J.B., et al. Progressive selection for neurovirulent genotypes in the brain of SIV-infected macaques. AIDS 2006, 20:197-205.
24. Bading J.R., Yamada S., et al. Brain clearance of Alzheimer's amyloid-beta40 in the squirrel monkey: A SPECT study in a primate model of cerebral amyloid angiopathy. J. Drug Target 2002, 10:359-368.
25. Bai Y., Narayan K., et al. Spinal cord involvement in the nonhuman primate model of Lyme disease. Lab. Invest 2004, 84:160-172.
26. Bailey C., Mansfield K. Emerging and reemerging infectious diseases of nonhuman primates in the laboratory setting. Vet. Pathol 2010, 47:462-481.
27. Barraud Q., Lambrecq V., et al. Sleep disorders in Parkinson's disease: The contribution of the MPTP non-human primate model. Exp. Neurol 2009, 219:574-582.
28. Barry P.A., Lockridge K.M., et al. Nonhuman primate models of intrauterine cytomegalovirus infection. ILAR J 2006, 47:49-64.
29. Barry P.A., Pratt-Lowe E., et al. Cytomegalovirus activates transcription directed by the long terminal repeat of human immunodeficiency virus type 1. J. Virol 1990, 64:2932-2940.
30. Barry P.A., Pratt-Lowe E., et al. Molecular interactions of cytomegalovirus and the human and simian immunodeficiency viruses. J. Med. Primatol 1990, 19:327-337.
31. Barry P.A., Strelow L. Development of breeding populations of rhesus macaques (Macaca mulatta) that are specific pathogen-free for rhesus cytomegalovirus. Comp. Med 2008, 58:43-46.
32. Baskin G.B. Disseminated cytomegalovirus infection in immunodeficient rhesus monkeys. Am. J. Pathol 1987, 129:345-352.
33. Baskin G.B., Ratterree M., et al. Genetic galactocerebrosidase deficiency (globoid cell leukodystrophy, Krabbe disease) in rhesus monkeys (Macaca mulatta). Lab. Anim. Sci 1998, 48:476-482.
34. Batista-Morais N., Neilson-Rolim B., et al. Rabies in tamarins (Callithrix jacchus) in the state of Ceara, Brazil, a distinct viral variant?. Mem. Inst. Oswaldo. Cruz 2000, 95:609-610.
35. Beaver P.C., Blanchard J.L., et al. Invasive amebiasis in naturally infected New World and Old World monkeys with and without clinical disease. Am. J. Trop. Med. Hyg 1988, 39:343-352.
36. Bergin I.L., Campbell B., et al. Ependymal cyst in a cynomolgus macaque (Macaca fascicularis). J. Med. Primatol 2008, 37:239-244.
37. Bernacky B.J., Gibson S.V., et al. Laboratory Animal Medicine, Ch. 16 Nonhuman Primates 2002, Academic Press.
38. Bishop K.A., Broder C.C. Hendra and Nipah: Lethal zoonotic paramyxoviruses. Emerging Infections 2008, 155-187. American Society for Microbiology, Washington, DC. W.M. Scheld, S.M. Hammer, J.M. Hughes (Eds.).
39. Bishop K.A., Stantchev T.S., et al. Identification of Hendra virus G glycoprotein residues that are critical for receptor binding. J. Virol 2007, 81:5893-5901.
40. Bissel S.J., Wang G., et al. Macrophages relate presynaptic and postsynaptic damage in simian immunodeficiency virus encephalitis. Am. J. Pathol 2002, 160:927-941.
41. Bissel S.J., Wang G., et al. Longitudinal analysis of monocyte/macrophage infection in simian immunodeficiency virus-infected, CD8+ T-cell-depleted macaques that develop lentiviral encephalitis. Am. J. Pathol 2006, 168:1553-1569.
42. Bonaparte M.I., Dimitrov A.S., et al. Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus. Proc. Natl. Acad. Sci. USA 2005, 102:10652-10657.
43. Bons N., Mestre-Frances N., et al. Natural and experimental oral infection of nonhuman primates by bovine spongiform encephalopathy agents. Proc. Natl. Acad. Sci. USA 1999, 96:4046-4051.
44. Bons N., Mestre-Frances N., et al. Spontaneous spongiform encephalopathy in a young adult rhesus monkey. Lancet 1996, 348:55.
45. Bons N., Mestre-Frances N., et al. Prion immunoreactivity in brain, tonsil, gastrointestinal epithelial cells, and blood and lymph vessels in lemurian zoo primates with spongiform encephalopathy. C.R. Acad. Sci. III 1997, 320:971-979.
46. Booton G.C., Carmichael J.R., et al. Genotyping of Balamuthia mandrillaris based on nuclear 18S and mitochondrial 16S rRNA genes. Am. J. Trop. Med. Hyg 2003, 68:65-69.
47. Borda J.T., Alvarez X., et al. Clinical and immunopathologic alterations in rhesus macaques affected with globoid cell leukodystrophy. Am. J. Pathol 2008, 172:98-111.
48. Bossart K.N., Zhu Z., et al. A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection. PLoS Pathog 2009, 5:e1000642.
49. Boudreau R.L., McBride J.L., et al. Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice. Mol. Ther 2009, 17:1053-1063.
50. Brady A.G. Research techniques for the squirrel monkey (Saimiri sp.). ILAR J 2000, 41:10-18.
51. Brenneman D.E., Westbrook G.L., et al. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature 1988, 335:639-642.
52. Brok H.P., Uccelli A., et al. Myelin/oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in common marmosets: The encephalitogenic T cell epitope pMOG24-36 is presented by a monomorphic MHC class II molecule. J. Immunol 2000, 165:1093-1101.
53. Bronson R.T., Schoene W.C. Spontaneous pallido-nigral accumulation of iron pigment and spheroid-like structures in macaque monkeys. J. Neuropathol. Exp. Neurol 1980, 39:181-196.
54. Brown P., Preece M., et al. Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 2000, 55:1075-1081.
55. Brown P., Preece M.A., et al. "Friendly fire" in medicine: Hormones, homografts, and Creutzfeldt-Jakob disease. Lancet 1992, 340:24-27.
56. Bukrinsky M.I., Nottet H.S., et al. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: Implications for HIV-associated neurological disease. J. Exp. Med 1995, 181:735-745.
57. Burke R.L., Whitehouse C.A., et al. Epidemiology of invasive Klebsiella pneumoniae with hypermucoviscosity phenotype in a research colony of nonhuman primates. Comp. Med 2009, 59:589-597.
58. Burton N.C., Guilarte T.R. Manganese neurotoxicity: Lessons learned from longitudinal studies in nonhuman primates. Environ Health Perspect 2009, 117:325-332.
59. Butler T.M., Wiley G.L. Baseline values for adult baboon cerebrospinal fluid. Lab. Anim. Sci 1971, 21:123-124.
60. Cadavid D., O'Neill T., et al. Localization of Borrelia burgdorferi in the nervous system and other organs in a nonhuman primate model of Lyme disease. Lab. Invest 2000, 80:1043-1054.
61. Canfield P.J., Vogelnest L., et al. Amoebic meningoencephalitis caused by Balamuthia mandrillaris in an orangutan. Aust. Vet. J 1997, 75:97-100.
62. Carlisle M.S., Prociv P., et al. Cerebrospinal angiostrongyliasis in five captive tamarins (Sanguinus spp.). Aust. Vet. J 1998, 76:167-170.
63. Cenna J., Hunter M., et al. Replication-deficient rabies virus-based vaccines are safe and immunogenic in mice and nonhuman primates. J. Infect. Dis 2009, 200:1251-1260.
64. Chalifoux L.V., Hajema E.M. Septicemia and meningoencephalitis caused by Listeria monocytogenes in a neonatal Macaca fascicularis. J. Med. Primatol 1981, 10:336-339.
65. Chalmers D.T., Murgatroyd L.B., et al. A survey of the pathology of marmosets (Callithrix jacchus) derived from a marmoset breeding unit. Lab. Anim 1983, 17:270-279.
66. Chang W.L., Tarantal A.F., et al. A recombinant rhesus cytomegalovirus expressing enhanced green fluorescent protein retains the wild-type phenotype and pathogenicity in fetal macaques. J. Virol 2002, 76:9493-9504.
67. Chen Y., Deng W., et al. The pathologic features of neurocutaneous melanosis in a cynomolgus macaque. Vet. Pathol 2009, 46:773-775.
68. Choi Y.K., Simon M.A., et al. Fatal measles virus infection in Japanese macaques (Macaca fuscata). Vet. Pathol 1999, 36:594-600.
69. Chrisp C.E., Cohen B.J., et al. Tuberculosis in a squirrel monkey (Saimiri sciureus). J. Am. Vet. Med. Assoc 1968, 153:918-922.
70. Chua K.B., Bellini W.J., et al. Nipah virus: A recently emergent deadly paramyxovirus. Science 2000, 288:1432-1435.
71. Churn S.B., Limbrick D., et al. Excitotoxic activation of the NMDA receptor results in inhibition of calcium/calmodulin kinase II activity in cultured hippocampal neurons. J. Neurosci 1995, 15:3200-3214.
72. Clarren S.K., Astley S.J., et al. Cognitive and behavioral deficits in nonhuman primates associated with very early embryonic binge exposures to ethanol. J. Pediatr 1992, 121:789-796.
73. Clements J.E., Babas T., et al. The central nervous system as a reservoir for simian immunodeficiency virus (SIV): Steady-state levels of SIV DNA in brain from acute through asymptomatic infection. J. Infect. Dis 2002, 186:905-913.
74. Clements J.E., Li M., et al. The central nervous system is a viral reservoir in simian immunodeficiency virus-infected macaques on combined antiretroviral therapy: A model for human immunodeficiency virus patients on highly active antiretroviral therapy. J. Neurovirol 2005, 11:180-189.
75. Clements J.E., Mankowski J.L., et al. The accelerated simian immunodeficiency virus macaque model of human immunodeficiency virus-associated neurological disease: From mechanism to treatment. J. Neurovirol 2008, 14:309-317.
76. Cogan D.G., Witt E.D., et al. Ocular signs in thiamine-deficient monkeys and in Wernicke's disease in humans. Arch. Ophthalmol 1985, 103:1212-1220.
77. Cohen J.I., Moskal T., et al. Varicella in chimpanzees. J. Med. Virol 1996, 50:289-292.
78. Collinge J. Prion diseases of humans and animals: Their causes and molecular basis. Annu. Rev. Neurosci 2001, 24:519-550.
79. Collinge J. Molecular neurology of prion disease. J. Neurol. Neurosurg. Psychiatry 2005, 76:906-919.
80. Collinge J., Clarke A.R. A general model of prion strains and their pathogenicity. Science 2007, 318:930-936.
81. Compston A., Coles A. Multiple sclerosis. Lancet 2008, 372:1502-1517.
82. Cork L.C., Walker L.C. Age-related lesions. Monographs on Pathology of Laboratory Animals, Nonhuman Primates 1993, Vol. 2:173-183. Springer-Verlag, New York, NY. T.C. Jones, U. Mohr, R.D. Hunt (Eds.).
83. Coulibaly C., Hack R., et al. A natural asymptomatic herpes B virus infection in a colony of laboratory brown capuchin monkeys (Cebus apella). Lab. Anim 2004, 38:432-438.
84. Cunningham A.A., Buxton D., et al. An epidemic of toxoplasmosis in a captive colony of squirrel monkeys (Saimiri sciureus). J. Comp. Pathol 1992, 107:207-219.
85. Cupp C.J., Uemura E. Age-related changes in prefrontal cortex of Macaca mulatta: Quantitative analysis of dendritic branching patterns. Exp. Neurol 1980, 69:143-163.
86. Dang X., Wuthrich C., et al. Productive simian virus 40 infection of neurons in immunosuppressed Rhesus monkeys. J. Neuropathol. Exp. Neurol 2008, 67:784-792.
87. Dantas-Torres F., Oliveira-Filho E.F. Human exposure to potential rabies virus transmitters in Olinda, State of Pernambuco, between 2002 and 2006. Rev. Soc. Bras. Med. Trop 2007, 40:617-621.
88. de Brabander J.M., Kramers R.J., et al. Layer-specific dendritic regression of pyramidal cells with ageing in the human prefrontal cortex. Eur. J. Neurosci 1998, 10:1261-1269.
89. de Crespigny A.J., D'Arceuil H.E., et al. Acute studies of a new primate model of reversible middle cerebral artery occlusion. J. Stroke Cerebrovasc. Dis 2005, 14:80-87.
90. DeLong M.R. Primate models of movement disorders of basal ganglia origin. Trends Neurosci 1990, 13:281-285.
91. Desrosiers R. Nonhuman lentiviruses. Fields virology 2007, Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, 2: 2 v. (xix, 3091, 86 p.). B.N. Fields, D.M. Knipe, P.M. Howley (Eds.).
92. Desrosiers R.C., Hansen-Moosa A., et al. Macrophage-tropic variants of SIV are associated with specific AIDS-related lesions but are not essential for the development of AIDS. Am. J. Pathol 1991, 139:29-35.
93. Dickson D.W., Braak H., et al. Neuropathological assessment of Parkinson's disease: Refining the diagnostic criteria. Lancet Neurol 2009, 8:1150-1157.
94. Dietz H.H., Henriksen P., et al. Toxoplasmosis in a colony of New World monkeys. Vet. Parasitol 1997, 68:299-304.
95. DiFiglia M. Excitotoxic injury of the neostriatum: A model for Huntington's disease. Trends Neurosci 1990, 13:286-289.
96. DiFiglia M., Sena-Esteves M., et al. Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits. Proc. Natl. Acad. Sci. USA 2007, 104:17204-17209.
97. Dinoso J.B., Rabi S.A., et al. A simian immunodeficiency virus-infected macaque model to study viral reservoirs that persist during highly active antiretroviral therapy. J. Virol 2009, 83:9247-9257.
98. Draper C.C., Killick-Kindrick R., et al. Experimental toxoplasmosis in chimpanzees. Br. Med. J 1971, 2:375-378.
99. Duan H., Wearne S.L., et al. Age-related dendritic and spine changes in corticocortically projecting neurons in macaque monkeys. Cereb. Cortex 2003, 13:950-961.
100. Earnest M.P., Thomas G.E., et al. The sudden unexplained death syndrome in epilepsy: Demographic, clinical, and postmortem features. Epilepsia 1992, 33:310-316.
101. Eaton B.T., Broder C.C., et al. Hendra and Nipah viruses: Different and dangerous. Nat. Rev. Microbiol 2006, 4:23-35.
102. Eaton B.T., Macknzie J.S., et al. Henipaviruses. Fields Virology 2007, 1587-1600. Lippincott Williams & Wilkins, Philadelphia. 5th ed. D.M. Knipe, P.M. Howley (Eds.).
103. Eberling J.L., Kells A.P., et al. Functional effects of AAV2-GDNF on the dopaminergic nigrostriatal pathway in parkinsonian rhesus monkeys. Hum. Gene. Ther 2009, 20:511-518.
104. Ehlers B., Ochs A., et al. Novel simian homologues of Epstein-Barr virus. J. Virol 2003, 77:10695-10699.
105. Eisele P.H., Morgan J.P., et al. Skeletal lesions and anemia associated with ascorbic acid deficiency in juvenile rhesus macaques. Lab. Anim. Sci 1992, 42:245-249.
106. El Mubarak H.S., Yuksel S., et al. Infection of cynomolgus macaques (Macaca fascicularis) and rhesus macaques (Macaca mulatta) with different wild-type measles viruses. J. Gen. Virol 2007, 88:2028-2034.
107. Ellis R., Langford D., et al. HIV and antiretroviral therapy in the brain: Neuronal injury and repair. Nat. Rev. Neurosci 2007, 8:33-44.
108. Emborg M.E. Nonhuman primate models of Parkinson's disease. ILAR J 2007, 48:339-355.
109. Emborg M.E., Ma S.Y., et al. Age-related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys. J. Comp. Neurol 1998, 401:253-265.
110. Epiphanio S., Guimaraes M.A., et al. Toxoplasmosis in golden-headed lion tamarins (Leontopithecus chrysomelas) and emperor marmosets (Saguinus imperator) in captivity. J. Zoo. Wildl. Med 2000, 31:231-235.
111. Eslamboli A. Marmoset monkey models of Parkinson's disease: Which model, when and why?. Brain Res. Bull 2005, 68:140-149.
112. Eslamboli A., Georgievska B., et al. Continuous low-level glial cell line-derived neurotrophic factor delivery using recombinant adeno-associated viral vectors provides neuroprotection and induces behavioral recovery in a primate model of Parkinson's disease. J. Neurosci 2005, 25:769-777.
113. Espana C., Gajdusek D.C., et al. Transmission of Creutzfeldt-Jakob disease to the stumptail macaque (Macaca arctoides). Proc. Soc. Exp. Biol. Med 1975, 149:723-724.
114. Eugenin E.A., King J.E., et al. HIV-tat induces formation of an LRP-PSD-95-NMDAR-nNOS complex that promotes apoptosis in neurons and astrocytes. Proc. Natl. Acad. Sci. USA 2007, 104:3438-3443.
115. Everall I.P., Heaton R.K., et al. Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center. Brain Pathol 1999, 9:209-217.
116. Favoretto S.R., de Mattos C.C., et al. Rabies in marmosets (Callithrix jacchus), Ceara, Brazil. Emerg. Infect. Dis 2001, 7:1062-1065.
117. Fernandes H.B., Baimbridge K.G., et al. Mitochondrial sensitivity and altered calcium handling underlie enhanced NMDA-induced apoptosis in YAC128 model of Huntington's disease. J. Neurosci 2007, 27:13614-13623.
118. Fortman J.D., Hewitt T.A., et al. The Laboratory Nonhuman Primate 2002, CRC Press, Boca Raton.
119. Fox J.G., Rohovsky M.W. Meningitis caused by Klebsiella spp. in two rhesus monkeys. J. Am. Vet. Med. Assoc 1975, 167:634-636.
120. Fox J.G., Soave O.A. Pneumococcic meningoencephalitis in a rhesus monkey. J. Am. Vet. Med. Assoc 1971, 159:1595-1597.
121. Franka R., Wu X., et al. Rabies virus pathogenesis in relationship to intervention with inactivated and attenuated rabies vaccines. Vaccine 2009, 27:7149-7155.
122. Fukuda S., del Zoppo G.J. Models of focal cerebral ischemia in the nonhuman primate. ILAR J 2003, 44:96-104.
123. Fung H.C., Scholz S., et al. Genome-wide genotyping in Parkinson's disease and neurologically normal controls: First stage analysis and public release of data. Lancet Neurol 2006, 5:911-916.
124. Furlan R., Cuomo C., et al. Animal models of multiple sclerosis. Methods Mol. Biol 2009, 549:157-173.
125. Gajdusek D.C. Paradoxes of aspiration for and of children in primitive and isolated cultures. Pediatr. Res 1990, 27:S59-S61.
126. Gajdusek D.C., Gibbs C.J. Transmission of kuru from man to rhesus monkey (Macaca mulatta) 8 and one-half years after inoculation. Nature 1972, 240:351.
127. Gallagher M., Rapp P.R. The use of animal models to study the effects of aging on cognition. Annu. Rev. Psychol 1997, 48:339-370.
128. Galler R., Pugachev K.V., et al. Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil. Virology 2001, 290:309-319.
129. Garcia A., Nambiar P.R., et al. Staphylococcal meningoencephalitis, nematodiasis, and typhlocolitis in a squirrel monkey (Saimiri sciureus). J. Med. Primatol 2009, 38:377-381.
130. Garcia J.H., Kamijyo Y. Cerebral infarction. Evolution of histopathological changes after occlusion of a middle cerebral artery in primates. J. Neuropathol. Exp. Neurol 1974, 33:408-421.
131. Gardner M.B., Luciw P.A. Macaque models of human infectious disease. ILAR J 2008, 49:220-255.
132. Gardner S.D., Knowles W.A., et al. Characterization of a new polyomavirus (Polyomavirus papionis-2) isolated from baboon kidney cell cultures. Arch. Virol 1989, 105:223-233.
133. Gaskill P.J., Watry D.D., et al. Development and characterization of positively selected brain-adapted SIV. Virol. J 2005, 2:44.
134. Gazzaley A.H., Thakker M.M., et al. Preserved number of entorhinal cortex layer II neurons in aged macaque monkeys. Neurobiol. Aging 1997, 18:549-553.
135. Geisbert T.W., Daddario-DiCaprio K.M., et al. Development of an acute and highly pathogenic nonhuman primate model of Nipah virus infection. PLoS One 2010, 5:e10690.
136. Genain C.P., Hauser S.L. Creation of a model for multiple sclerosis in Callithrix jacchus marmosets. J. Mol. Med 1997, 75:187-197.
137. Genain C.P., Hauser S.L. Experimental allergic encephalomyelitis in the New World monkey Callithrix jacchus. Immunol. Rev 2001, 183:159-172.
138. Gendelman H.E. Biomarkers, laboratory, and animal models for the design and development of adjunctive therapies for HIV-1 dementia and other neuroinflammatory disorders. J. Neuroimmune. Pharmacol 2007, 2:8-13.
139. Geretschlager E., Russ H., et al. Suboccipital puncture for cerebrospinal fluid in the common marmoset (Callithrix jacchus). Lab. Anim 1987, 21:91-94.
140. Geula C., Nagykery N., et al. Amyloid-beta deposits in the cerebral cortex of the aged common marmoset (Callithrix jacchus): Incidence and chemical composition. Acta. Neuropathol 2002, 103:48-58.
141. Gibbs C.J., Gajdusek D.C. Transmission of scrapie to the cynomolgus monkey (Macaca fascicularis). Nature 1972, 236:73-74.
142. Gilberto D.B., Zeoli A.H., et al. An alternative method of chronic cerebrospinal fluid collection via the cisterna magna in conscious rhesus monkeys. Contemp. Top. Lab. Anim. Sci 2003, 42:53-59.
143. Gliatto J.M., Bronson R.T. Spontaneous Pallidonigral Spheroids and iron pigment accumulation, Macaques. Monographs on Pathology of Laboratory Animals 1993, Springer-Verlag, New York, NY.
144. Goh K.J., Tan C.T., et al. Clinical features of Nipah virus encephalitis among pig farmers in Malaysia. N. Engl. J. Med 2000, 342:1229-1235.
145. Gonzalez R.G., Cheng L.L., et al. Early brain injury in the SIV-macaque model of AIDS. AIDS 2000, 14:2841-2849.
146. Gonzalez R.G., Greco J.B., et al. New insights into the neuroimmunity of SIV infection by magnetic resonance spectroscopy. J. Neuroimmune. Pharmacol 2006, 1:152-159.
147. Gonzalo A., Montoyo E. Klebsiella pneumoniae infection in a New World nonhuman primate center. Laboratory Primate Newsletter 1991, 30:13-20.
148. Gould E., Reeves A.J., et al. Hippocampal neurogenesis in adult Old World primates. Proc. Natl. Acad. Sci. USA 1999, 96:5263-5267.
149. Gould E., Reeves A.J., et al. Neurogenesis in the neocortex of adult primates. Science 1999, 286:548-552.
150. Goulet M., Madras B.K. D(1) dopamine receptor agonists are more effective in alleviating advanced than mild parkinsonism in 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated monkeys. J. Pharmacol. Exp. Ther 2000, 292:714-724.
151. Gozalo A.S., Maximova O.A., et al. Visceral and neural larva migrans in rhesus macaques. J. Am. Assoc. Lab. Anim. Sci 2008, 47:64-67.
152. Gray W.L. Simian varicella in old world monkeys. Comp. Med 2008, 58:22-30.
153. Gribble D.H., Haden C.C., et al. Spontaneous progressive multifocal leukoencephalopathy (PML) in macaques. Nature 1975, 254:602-604.
154. Griffin D.E. Fields virology 2007, Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia.
155. Grigorev V.V., Dranyi O.A., et al. Comparative study of action mechanisms of dimebon and memantine on AMPA- and NMDA-subtypes glutamate receptors in rat cerebral neurons. Bull. Exp. Biol. Med 2003, 136:474-477.
156. Gunderson V.M., Dubach M., et al. Development of a model of status epilepticus in pigtailed macaque infant monkeys. Dev. Neurosci 1999, 21:352-364.
157. Gupta R.G., Kelly K.M., et al. HIV and SIV induce alterations in CNS CaMKII expression and activation: A potential mechanism for cognitive impairment. Am. J. Pathol 2010, 176:2776-2784.
158. Guscetti F., Mathis A., et al. Overt fatal and chronic subclinical Encephalitozoon cuniculi microsporidiosis in a colony of captive emperor tamarins (Saguinus imperator). J. Med. Primatol 2003, 32:111-119.
159. Haas J., Hug A., et al. Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. Eur. J. Immunol 2005, 35:3343-3352.
160. Hafler D.A., Compston A., et al. Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med 2007, 357:851-862.
161. Haltia M. The neuronal ceroid-lipofuscinoses. J. Neuropathol. Exp. Neurol 2003, 62:1-13.
162. Hambleton P., Baskerville A., et al. Some normal clinical chemistry values for cerebrospinal fluid of the rhesus monkey (Macaca mulatta). Lab. Anim 1981, 15:181-186.
163. Haq A., Sharma A., et al. Experimental infection of rhesus monkeys with Entamoeba histolytica mimics human infection. Lab. Anim. Sci 1985, 35:481-484.
164. Hardy J., Cai H., et al. Genetics of Parkinson's disease and parkinsonism. Ann. Neurol 2006, 60:389-398.
165. Hardy J., Lewis P., et al. The genetics of Parkinson's syndromes: A critical review. Curr. Opin. Genet. Dev 2009, 19:254-265.
166. Hashimoto M., Boyer J.L., et al. Induction of protective immunity to anthrax lethal toxin with a nonhuman primate adenovirus-based vaccine in the presence of preexisting anti-human adenovirus immunity. Infect. Immun 2005, 73:6885-6891.
167. Hauser S.L., Oksenberg J.R. The neurobiology of multiple sclerosis: Genes, inflammation, and neurodegeneration. Neuron 2006, 52:61-76.
168. Haustein S.V., Kolterman A.J., et al. Nonhuman primate infections after organ transplantation. ILAR J 2008, 49:209-219.
169. Hayashi N., Matsubara M., et al. Nef of HIV-1 interacts directly with calcium-bound calmodulin. Protein Sci 2002, 11:529-537.
170. Helke K.L., Queen S.E., et al. 14-3-3 protein in CSF: An early predictor of SIV CNS disease. J. Neuropathol. Exp. Neurol 2005, 64:202-208.
171. Hendrickx A.G., Peterson P.E. Perspectives on the use of the baboon in embryology and teratology research. Hum. Reprod. Update 1997, 3:575-592.
172. Hendrickx A.G., Prahalada S. Reproduction and Development. Teratology and Enbryogenesis 1986, Alan R. Liss, Inc.
173. Herndon J.G., Lacreuse A., et al. Age-related decline in DHEAS is not related to cognitive impairment in aged monkeys. Neuroreport 1999, 10:3507-3511.
174. Herndon J.G., Moss M.B., et al. Patterns of cognitive decline in aged rhesus monkeys. Behav. Brain Res 1997, 87:25-34.
175. Herring J.M., Reyes M., et al. Glioblastoma multiforme in a baboon. Lab. Anim. Sci 1990, 40:645-647.
176. Herzog C., Sales N., et al. Tissue distribution of bovine spongiform encephalopathy agent in primates after intravenous or oral infection. Lancet 2004, 363:422-428.
177. Hof P.R., Nimchinsky E.A., et al. Numbers of meynert and layer IVB cells in area V1: A stereologic analysis in young and aged macaque monkeys. J. Comp. Neurol 2000, 420:113-126.
178. Holman R.C., Janssen R.S., et al. Epidemiology of progressive multifocal leukoencephalopathy in the United States: Analysis of national mortality and AIDS surveillance data. Neurology 1991, 41:1733-1736.
179. Hoopes C.W., Jerome C.P. Oral-facial clefts and associated malformations in the squirrel monkey (Saimiri sciureus). J. Med. Primatol 1987, 16:203-209.
180. Horn T.F., Huitron-Resendiz S., et al. Early physiological abnormalities after simian immunodeficiency virus infection. Proc. Natl. Acad. Sci. USA 1998, 95:15072-15077.
181. Howe H.A., Bodian D. Second attacks of poliomyelitis: An experimental study. J. Exp. Med 1941, 74:145-166.
182. Hsiung G.D., Black F.L., et al. Susceptibility of primates to viruses in relation to taxonomic classification. Evolutionary and Genetic Biology of Primates 1964, Vol. 2:1-23. Academic Press, New York, NY. J. Buettner-Janusch (Ed.).
183. Huan J., Culbertson N., et al. Decreased FOXP3 levels in multiple sclerosis patients. J. Neurosci. Res 2005, 81:45-52.
184. Hubbard G.B., Soike K.F., et al. An encephalomyocarditis virus epizootic in a baboon colony. Lab. Anim. Sci 1992, 42:233-239.
185. Huff J.L., Barry P.A. B-virus (Cercopithecine herpesvirus 1) infection in humans and macaques: Potential for zoonotic disease. Emerg. Infect. Dis 2003, 9:246-250.
186. Hult B., Chana G., et al. Neurobiology of HIV. Int. Rev. Psychiatry 2008, 20:3-13.
187. Hunt R.D., Blake B.J. Nonhuman primates. Herpesvirus B Infection 1993, Springer-Verlag, Berlin, New York.
188. Hurley J.P., Ilyinskii P.O., et al. A malignant astrocytoma containing simian virus 40 DNA in a macaque infected with simian immunodeficiency virus. J. Med. Primatol 1997, 26:172-180.
189. Iltis J.P., Arrons M.C., et al. Simian varicella virus (delta herpesvirus) infection of patas monkeys leading to pneumonia and encephalitis. Proc. Soc. Exp. Biol. Med 1982, 169:266-279.
190. Ilyinskii P.O., Daniel M.D., et al. Genetic analysis of simian virus 40 from brains and kidneys of macaque monkeys. J. Virol 1992, 66:6353-6360.
191. Imbert C., Bezard E., et al. Comparison of eight clinical rating scales used for the assessment of MPTP-induced parkinsonism in the Macaque monkey. J. Neurosci. Methods 2000, 96:71-76.
192. Imperiale M.J., Major E.O. Fields virology 2007, Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia.
193. Ino H., Hayashi K., et al. Analysis of the genome of an Epstein-Barr-virus (EBV)-related herpesvirus in a cynomolgus monkey cell line (Si-IIA). Acta. Med. Okayama 1997, 51:207-212.
194. Isacson O. Cell therapy ahead for Parkinson's disease. Science 2009, 326:1060.
195. Isacson O., Kordower J.H. Future of cell and gene therapies for Parkinson's disease. Ann. Neurol 2008, 64(Suppl. 2):S122-S138.
196. Isacson O., Riche D., et al. A primate model of Huntington's disease: Cross-species implantation of striatal precursor cells to the excitotoxically lesioned baboon caudate-putamen. Exp. Brain Res 1989, 75:213-220.
197. Jackson G.S., Collinge J. The molecular pathology of CJD: old and new variants. Mol. Pathol 2001, 54:393-399.
198. Jacobs B., Driscoll L., et al. Life-span dendritic and spine changes in areas 10 and 18 of human cortex: A quantitative Golgi study. J. Comp. Neurol 1997, 386:661-680.
199. Jacobs B., Schall M., et al. A quantitative dendritic analysis of Wernicke's area in humans. II. Gender, hemispheric, and environmental factors. J. Comp. Neurol 1993, 327:97-111.
200. Jakowec M.W., Petzinger G.M. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned model of parkinson's disease, with emphasis on mice and nonhuman primates. Comp. Med 2004, 54:497-513.
201. Jalanko A., Braulke T. Neuronal ceroid lipofuscinoses. Biochim. Biophys. Acta 2009, 1793:697-709.
202. Jasty V., Kowalski R.L., et al. An unusual case of generalized ceroid-lipofuscinosis in a cynomolgus monkey. Vet. Pathol 1984, 21:46-50.
203. Jerome C.P. Congenital malformations and twinning in a breeding colony of Old World monkeys. Lab. Anim. Sci 1987, 37:624-630.
204. Jerome C.P. Craniorachischisis in a squirrel monkey. Lab. Anim. Sci 1987, 37:76-79.
205. Jiang Z.G., Piggee C., et al. Glutamate is a mediator of neurotoxicity in secretions of activated HIV-1-infected macrophages. J. Neuroimmunol 2001, 117:97-107.
206. Johne R., Enderlein D., et al. Novel polyomavirus detected in the feces of a chimpanzee by nested broad-spectrum PCR. J. Virol 2005, 79:3883-3887.
207. Jordan-Sciutto K.L., Wang G., et al. Induction of cell-cycle regulators in simian immunodeficiency virus encephalitis. Am. J. Pathol 2000, 157:497-507.
208. Jortner B.S., Percy D.H. The Nervous System 1978, Pathology of Laboratory Animals.
209. Joseph J., Clifford D., et al. Planning future strategies for domestic and international neuroAIDS research. J. Neuroimmune. Pharmacol 2009, 4:283-297. July 24-25, 2008.
210. Juan-Salles C., Prats N., et al. Fatal acute toxoplasmosis in three golden lion tamarins (Leontopithecus rosalia). J. Zoo. Wildl. Med 1998, 29:55-60.
211. Juan-Salles C., Ramos-Vara J.A., et al. Spontaneous herpes simplex virus infection in common marmosets (Callithrix jacchus). J. Vet. Diagn. Invest 1997, 9:341-345.
212. Kap Y.S., Smith P., et al. Fast progression of recombinant human myelin/oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis in marmosets is associated with the activation of MOG34-56-specific cytotoxic T cells. J. Immunol 2008, 180:1326-1337.
213. Kaul M., Zheng J., et al. HIV-1 infection and AIDS: Consequences for the central nervous system. Cell Death Differ 2005, 12(Suppl. 1):878-892.
214. Kaur A., Daniel M.D., et al. Cytotoxic T-lymphocyte responses to cytomegalovirus in normal and simian immunodeficiency virus-infected rhesus macaques. J. Virol 1996, 70:7725-7733.
215. Kaur A., Hale C.L., et al. Decreased frequency of cytomegalovirus (CMV)-specific CD4+ T lymphocytes in simian immunodeficiency virus-infected rhesus macaques: Inverse relationship with CMV viremia. J. Virol 2002, 76:3646-3658.
216. Kaur A., Kassis N., et al. Direct relationship between suppression of virus-specific immunity and emergence of cytomegalovirus disease in simian AIDS. J. Virol 2003, 77:5749-5758.
217. Kean L.S., Adams A.B., et al. Induction of chimerism in rhesus macaques through stem cell transplant and costimulation blockade-based immunosuppression. Am. J. Transplant 2007, 7:320-335.
218. Kebir H., Kreymborg K., et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat. Med 2007, 13:1173-1175.
219. Keeble S.A. B virus infection in monkeys. Ann. N.Y. Acad. Sci 1960, 85:960-969.
220. Kenet G., Kirkham F., et al. Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: A multicentre cohort study. Lancet Neurol 2007, 6:595-603.
221. Kennedy P.G., Grinfeld E., et al. Neuronal localization of simian varicella virus DNA in ganglia of naturally infected African green monkeys. Virus Genes 2004, 28:273-276.
222. Kenyon R.H., Rippy M.K., et al. Infection of Macaca radiata with viruses of the tick-borne encephalitis group. Microb. Pathog 1992, 13:399-409.
223. Khan S., Peng X., et al. Characterization of the New World monkey homologues of human poliovirus receptor CD155. J. Virol 2008, 82:7167-7179.
224. Kimura N., Tanemura K., et al. Age-related changes of Alzheimer's disease-associated proteins in cynomolgus monkey brains. Biochem. Biophys. Res. Commun 2003, 310:303-311.
225. King N.W. Nonhuman Primates. Simian Immunodeficiency Virus Infections 1993, Springer-Verlag, Berlin, New York.
226. King N.W. Nonhuman primates. Simian Virus 40 Infection 1993, Springer-Verlag, Berlin, New York.
227. Kloster R., Engelskjon T. Sudden unexpected death in epilepsy (SUDEP): A clinical perspective and a search for risk factors. J. Neurol. Neurosurg. Psychiatry 1999, 67:439-444.
228. Kodama H., Koyama T., et al. Two cases of natural infection of Angiostrongylus cantonensis in cynomolgus monkeys (Macaca fascicularis) (author's transl). Jikken Dobutsu 1981, 30:251-261.
229. Kodama R., Yang X., et al. Age-related lesions in the cerebrum in middle-aged female cynomolgus monkeys. Toxicol. Pathol 2010, 38:303-311.
230. Kolappaswamy K., Shipley S.T., et al. Methicillin-resistant Staphylococcus non-aureus infection in an irradiated rhesus macaque (Macaca mulatta). J. Am. Assoc. Lab. Anim. Sci 2008, 47.
231. Kovacs G.G., Budka H. Molecular pathology of human prion diseases. Int. J. Mol. Sci 2009, 10:976-999.
232. Krasnianski A., Meissner B., et al. Clinical findings and diagnostic tests in Creutzfeldt-Jakob disease and variant Creutzfeldt-Jakob disease. Folia Neuropathol 2004, 42(Suppl. B):24-38.
233. Laast V.A., Pardo C.A., et al. Pathogenesis of simian immunodeficiency virus-induced alterations in macaque trigeminal ganglia. J. Neuropathol. Exp. Neurol 2007, 66:26-34.
234. Lacreuse A., Herndon J.G., et al. Spatial cognition in rhesus monkeys: Male superiority declines with age. Horm. Behav 1999, 36:70-76.
235. Lane J.H., Sasseville V.G., et al. Neuroinvasion by simian immunodeficiency virus coincides with increased numbers of perivascular macrophages/microglia and intrathecal immune activation. J. Neurovirol 1996, 2:423-432.
236. Langford D., Grigorian A., et al. The role of mitochondrial alterations in the combined toxic effects of human immunodeficiency virus Tat protein and methamphetamine on calbindin positive-neurons. J. Neurovirol 2004, 10:327-337.
237. Langford D., Hurford R., et al. Signalling crosstalk in FGF2-mediated protection of endothelial cells from HIV-gp120. BMC Neurosci 2005, 6:8.
238. Langford D., Masliah E. Crosstalk between components of the blood brain barrier and cells of the CNS in microglial activation in AIDS. Brain Pathol 2001, 11:306-312.
239. LaRue R., Myers S., et al. A wild-type porcine encephalomyocarditis virus containing a short poly(C) tract is pathogenic to mice, pigs, and cynomolgus macaques. J. Virol 2003, 77:9136-9146.
240. Lasky R.E., Laughlin N.K., et al. The effects of elevated blood lead levels and succimer chelation therapy on physical growth in developing rhesus monkeys. Environ. Res 2001, 87:21-30.
241. Lasmezas C.I., Fournier J.G., et al. Adaptation of the bovine spongiform encephalopathy agent to primates and comparison with Creutzfeldt-Jakob disease: Implications for human health. Proc. Natl. Acad. Sci. USA 2001, 98:4142-4147.
242. Lausen N.C., Richter A.G., et al. Pseudomonas aeruginosa infection in squirrel monkeys. J. Am. Vet. Med. Assoc 1986, 189:1216-1218.
243. Lee G., Danneman P., et al. Use of chlorine dioxide for antimicrobial prophylactic maintenance of cephalic recording devices in rhesus macaques (Macaca mulatta). Contemp. Top. Lab. Anim. Sci 1998, 37:59-63.
244. Lees A.J., Hardy J., et al. Parkinson's disease. Lancet 2009, 373:2055-2066.
245. Lehner N.D., Bullock B.C., et al. Simian varicella infection in the African green monkey (Cercopithecus aethiops). Lab. Anim. Sci 1984, 34:281-285.
246. Lemere C.A., Oh J., et al. Cerebral amyloid-beta protein accumulation with aging in cotton-top tamarins: A model of early Alzheimer's disease?. Rejuvenation Res 2008, 11:321-332.
247. Lentz M.R., Kim W.K., et al. Changes in MRS neuronal markers and T cell phenotypes observed during early HIV infection. Neurology 2009, 72:1465-1472.
248. Lepper, T. W., Oliveira, E., et al. Lead inhibits in vitro creatine kinase and pyruvate kinase activity in brain cortex of rats. Toxicol In Vitro 24, 1045-1051.
249. Lermontova N.N., Redkozubov A.E., et al. Dimebon and tacrine inhibit neurotoxic action of beta-amyloid in culture and block L-type Ca(2+) channels. Bull. Exp. Biol. Med 2001, 132:1079-1083.
250. Levin E.D., Bowman R.E. Long-term effects of chronic postnatal lead exposure on delayed spatial alternation in monkeys. Neurotoxicol. Teratol 1988, 10:505-510.
251. Levin E.D., Schantz S.L., et al. Delayed spatial alternation deficits resulting from perinatal PCB exposure in monkeys. Arch. Toxicol 1988, 62:267-273.
252. Levin E.D., Schneider M.L., et al. Behavioral effects of developmental lead exposure in rhesus monkeys. Dev. Psychobiol 1988, 21:371-382.
253. Lewis A.D., Colgin L.M. Cerebral venous thrombosis. J. Child Neurol 2008, 23:356-357.
254. Lipton S.A., Brenneman D.E., et al. gp120 and neurotoxicity in vivo. Trends Pharmacol. Sci 1995, 16:122.
255. Lipton S.A., Sucher N.J., et al. Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron 1991, 7:111-118.
256. Liu Y., D'Arceuil H.E., et al. Serial diffusion tensor MRI after transient and permanent cerebral ischemia in nonhuman primates. Stroke 2007, 38:138-145.
257. Lodmell D.L., Ray N.B., et al. DNA immunization protects nonhuman primates against rabies virus. Nat. Med 1998, 4:949-952.
258. London W.T., Houff S.A., et al. Viral-induced astrocytomas in squirrel monkeys. Prog. Clin. Biol. Res 1983, 105:227-237.
259. London W.T., Martinez A.J., et al. Experimental congenital disease with simian cytomegalovirus in rhesus monkeys. Teratology 1986, 33:323-331.
260. Lorenz D., Albrecht P. Susceptibility of tamarins (Saguinus) to measles virus. Lab. Anim. Sci 1980, 30:661-665.
261. Lowenstine L.J., Lerche N.W., et al. Evidence for a lentiviral etiology in an epizootic of immune deficiency and lymphoma in stump-tailed macaques (Macaca arctoides). J. Med. Primatol 1992, 21:1-14.
262. Luby S.P., Rahman M., et al. Foodborne transmission of Nipah virus, Bangladesh. Emerg. Infect. Dis 2006, 12:1888-1894.
263. Lucey J.F., Behrman R.E. Thalidomide: Effect upon pregnancy in the rhesus monkey. Science 1963, 139:1295-1296.
264. Ludlage E., Mansfield K. Clinical care and diseases of the common marmoset (Callithrix jacchus). Comp. Med 2003, 53:369-382.
265. Luebcke E., Dubovi E., et al. Isolation and characterization of a chimpanzee alphaherpesvirus. J. Gen. Virol 2006, 87:11-19.
266. Luebke J.I., Chang Y.M., et al. Normal aging results in decreased synaptic excitation and increased synaptic inhibition of layer 2/3 pyramidal cells in the monkey prefrontal cortex. Neuroscience 2004, 125:277-288.
267. Luzi P., Rafi M.A., et al. Characterization of the rhesus monkey galactocerebrosidase (GALC) cDNA and gene and identification of the mutation causing globoid cell leukodystrophy (Krabbe disease) in this primate. Genomics 1997, 42:319-324.
268. Lyles D.S., Rupprecht C.E. Fields virology 2007, Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia.
269. Machotka S.V., Chapple F.E., et al. Cerebral tuberculosis in a rhesus monkey. J. Am. Vet. Med. Assoc 1975, 167:648-650.
270. Mack W.J., King R.G., et al. An improved functional neurological examination for use in nonhuman primate studies of focal reperfused cerebral ischemia. Neurol. Res 2003, 25:280-284.
271. Maclean C.J., Baker H.F., et al. Naturally occurring and experimentally induced beta-amyloid deposits in the brains of marmosets (Callithrix jacchus). J. Neural. Transm 2000, 107:799-814.
272. Madden L.J., Zandonatti M.A., et al. CD8+ cell depletion amplifies the acute retroviral syndrome. J Neurovirol 2004, 10(Suppl. 1):58-66.
273. Madras B.K., Canfield D.R., et al. Fluorescent and biotin probes for dopamine receptors: D1 and D2 receptor affinity and selectivity. Mol. Pharmacol 1990, 37:833-839.
274. Madras B.K., Fahey M.A., et al. Dopamine transporter (DAT) inhibitors alleviate specific parkinsonian deficits in monkeys: Association with DAT occupancy in vivo. J. Pharmacol. Exp. Ther 2006, 319:570-585.
275. Mahalingam R., Clarke P., et al. Prevalence and distribution of latent simian varicella virus DNA in monkey ganglia. Virology 1992, 188:193-197.
276. Mahalingam R., Smith D., et al. Simian varicella virus DNA in dorsal root ganglia. Proc. Natl. Acad. Sci. USA 1991, 88:2750-2752.
277. Mahalingam R., Traina-Dorge V., et al. Simian varicella virus reactivation in cynomolgus monkeys. Virology 2007, 368:50-59.
278. Mahalingam R., Traina-Dorge V., et al. Naturally acquired simian varicella virus infection in African green monkeys. J. Virol 2002, 76:8548-8550.
279. Major E.O., Vacante D.A., et al. Owl monkey astrocytoma cells in culture spontaneously produce infectious JC virus which demonstrates altered biological properties. J. Virol 1987, 61:1435-1441.
280. Maki T., Carville A., et al. SV40 infection associated with rituximab treatment after kidney transplantation in nonhuman primates. Transplantation 2008, 85:893-902.
281. Malherbe H., Strickland-Cholmley M. Simian herpesvirus SA8 from a baboon. Lancet 1969, 2:1427.
282. Malherbe H., Strickland-Cholmley M. Virus from baboons. Lancet 1969, 2:1300.
283. Mallucci G., Collinge J. Rational targeting for prion therapeutics. Nat. Rev. Neurosci 2005, 6:23-34.
284. Mankowski J.L., Clements J.E., et al. Searching for clues: Tracking the pathogenesis of human immunodeficiency virus central nervous system disease by use of an accelerated, consistent simian immunodeficiency virus macaque model. J. Infect. Dis 2002, 186(Suppl. 2):S199-S208.
285. Mankowski J.L., Queen S.E., et al. Cerebrospinal fluid markers that predict SIV CNS disease. J. Neuroimmunol 2004, 157:66-70.
286. Mankowski J.L., Queen S.E., et al. Accumulation of beta-amyloid precursor protein in axons correlates with CNS expression of SIV gp41. J. Neuropathol. Exp. Neurol 2002, 61:85-90.
287. Mansfield K.G., Lerch N.W., et al. Origins of simian immunodeficiency virus infection in macaques at the New England Regional Primate Research Center. J. Med. Primatol 1995, 24:116-122.
288. Maqbool A., Tahir M. Corpora Amylacea in human cadaveric brain age related differences. Biomedica 2008, 24:92-95.
289. Marchevsky R.S., Freire M.S., et al. Neurovirulence of yellow fever 17DD vaccine virus to rhesus monkeys. Virology 2003, 316:55-63.
290. Marcondes M.C., Flynn C., et al. Early antiretroviral treatment prevents the development of central nervous system abnormalities in simian immunodeficiency virus-infected rhesus monkeys. AIDS 2009, 23:1187-1195.
291. Marianneau P., Guillaume V., et al. Experimental infection of squirrel monkeys with Nipah virus. Emerg. Infect. Dis 2010, 16:507-510.
292. Marshall J.W., Ridley R.M., et al. Serial MRI, functional recovery, and long-term infarct maturation in a non-human primate model of stroke. Brain Res. Bull 2003, 61:577-585.
293. Martin J.E., Cole W.C., et al. Tuberculosis of the spine (Pott's disease) in a rhesus monkey (Macaca mulatta). J. Am. Vet. Med. Assoc 1968, 153:914-917.
294. Martin L.J., Sisodia S.S., et al. Amyloid precursor protein in aged nonhuman primates. Proc. Natl. Acad. Sci. USA 1991, 88:1461-1465.
295. Martino M.A., Hubbard G.B., et al. Clinical disease associated with simian agent 8 infection in the baboon. Lab. Anim. Sci 1998, 48:18-22.
296. Masliah E., Achim C.L., et al. Cellular neuropathology in HIV encephalitis. Res. Publ. Assoc. Res. Nerv. Ment. Dis 1994, 72:119-131.
297. Masliah E., Ge N., et al. Cortical dendritic pathology in human immunodeficiency virus encephalitis. Lab. Invest 1992, 66:285-291.
298. Massacesi L., Joshi N., et al. Experimental allergic encephalomyelitis in cynomolgus monkeys. Quantitation of T cell responses in peripheral blood. J. Clin. Invest 1992, 90:399-404.
299. Masters C.L., Alpers M.P., et al. Experimental kuru in the gibbon and sooty mangabey and Creutzfeldt-Jakob disease in the pigtailed macaque. With a summary of the host range of the subacute spongiform virus encephalopathies. J. Med. Primatol 1976, 5:205-209.
300. Matz-Rensing K., Jentsch K.D., et al. Fatal Herpes simplex infection in a group of common marmosets (Callithrix jacchus). Vet. Pathol 2003, 40:405-411.
301. Maximova O.A., Ward J.M., et al. Comparative neuropathogenesis and neurovirulence of attenuated flaviviruses in nonhuman primates. J. Virol 2008, 82:5255-5268.
302. McClure H.M. Tumors in nonhuman primates: Observations during a six-year period in the Yerkes primate center colony. Am. J. Phys. Anthropol 1973, 38:425-429.
303. Mead S. Prion disease genetics. Eur. J. Hum. Genet 2006, 14:273-281.
304. Mein L.E., Hoch R.M., et al. Encephalitogenic potential of myelin basic protein-specific T cells isolated from normal rhesus macaques. Am. J. Pathol 1997, 150:445-453.
305. Mendez I., Vinuela A., et al. Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years. Nat. Med 2008, 14:507-509.
306. Menini C., Silva-Barrat C. The photosensitive epilepsy of the baboon. A model of generalized reflex epilepsy. Adv. Neurol 1998, 75:29-47.
307. Merrill D.A., Roberts J.A., et al. Conservation of neuron number and size in entorhinal cortex layers II, III, and V/VI of aged primates. J. Comp. Neurol 2000, 422:396-401.
308. Mesic J.B., Fletcher G.H., et al. Megavoltage irradiation of epithelial tumors of the nasopharynx. Int. J. Radiat. Oncol. Biol. Phys 1981, 7:447-453.
309. Mestre-Frances N., Keller E., et al. Immunohistochemical analysis of cerebral cortical and vascular lesions in the primate Microcebus murinus reveal distinct amyloid beta1-42 and beta1-40 immunoreactivity profiles. Neurobiol. Dis 2000, 7:1-8.
310. Mesulam M.M., Van Hoesen G.W., et al. Clinical manifestations of chronic thiamine deficiency in rhesus monkey. Neurology 1977, 27:239-245.
311. Miller C.L., Kinsella J.M., et al. Endemic infections of Parastrongylus (=Angiostrongylus) costaricensis in two species of nonhuman primates, raccoons, and an opossum from Miami, Florida. J. Parasitol 2006, 92:406-408.
312. Miller N.L., Frenkel J.K., et al. Oral infections with Toxoplasma cysts and oocysts in felines, other mammals, and in birds. J. Parasitol 1972, 58:928-937.
313. Milush J.M., Kosub D., et al. Rapid dissemination of SIV following oral inoculation. AIDS 2004, 18:2371-2380.
314. Mocarski E.S., Shenk T.E., et al. Cytomegaloviruses. Fields virology 2007, Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, 2: 2 v. (xix, 3091, 86 p.). B.N. Fields, D.M. Knipe, P.M. Howley (Eds.).
315. Mohamed M.A., Lentz M.R., et al. Factor analysis of proton MR spectroscopic imaging data in HIV infection: Metabolite-derived factors help identify infection and dementia. Radiology 2010, 254:577-586.
316. Monsein L.H., Mathews V.P., et al. Irreversible regional cerebral ischemia: Serial MR imaging and proton MR spectroscopy in a nonhuman primate model. AJNR Am. J. Neuroradiol 1993, 14:963-970.
317. Montgomery M.M., Dean A.F., et al. Progressive dendritic pathology in cynomolgus macaques infected with simian immunodeficiency virus. Neuropathol. Appl. Neurobiol 1999, 25:11-19.
318. Moore T.L., Killiany R.J., et al. Impairment in abstraction and set shifting in aged rhesus monkeys. Neurobiol. Aging 2003, 24:125-134.
319. Moore T.L., Killiany R.J., et al. Executive system dysfunction occurs as early as middle-age in the rhesus monkey. Neurobiol. Aging 2006, 27:1484-1493.
320. Moore T.L., Schettler S.P., et al. Cognitive impairment in aged rhesus monkeys associated with monoamine receptors in the prefrontal cortex. Behav. Brain Res 2005, 160:208-221.
321. Mori K., Ringler D.J., et al. Complex determinants of macrophage tropism in env of simian immunodeficiency virus. J. Virol 1992, 66:2067-2075.
322. Morita M., Iida T., et al. Fatal herpesvirus tamarinus infection in cotton-topped marmosets (Saguinus oedipus). Jikken Dobutsu 1979, 28:537-550.
323. Morrison J.H., Hof P.R. Life and death of neurons in the aging brain. Science 1997, 278:412-419.
324. Moss M.B., Killiany R.J., et al. Recognition memory span in rhesus monkeys of advanced age. Neurobiol. Aging 1997, 18:13-19.
325. Murphy C.G., Lucas W.T., et al. Vaccine protection against simian immunodeficiency virus by recombinant strains of herpes simplex virus. J. Virol 2000, 74:7745-7754.
326. Nakamura S., Akiguchi I., et al. Age-related changes of pyramidal cell basal dendrites in layers III and V of human motor cortex: A quantitative Golgi study. Acta. Neuropathol 1985, 65:281-284.
327. Nakamura S., Nakayama H., et al. Histopathological studies on senile plaques and cerebral amyloid angiopathy in aged cynomolgus monkeys. Exp. Anim 1995, 43:711-718.
328. Narasimhan S., Caimano M.J., et al. Borrelia burgdorferi transcriptome in the central nervous system of non-human primates. Proc. Natl. Acad. Sci. USA 2003, 100:15953-15958.
329. Needleman H. Lead poisoning. Annu. Rev. Med 2004, 55:209-222.
330. Negrete O.A., Levroney E.L., et al. EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus. Nature 2005, 436:401-405.
331. Neubert D., Merker H.J., et al. Non-Human Primates: Developmental Biology and Toxicology 1988, Ueberreuter Wissenschaft, Vienna.
332. Nilsson L., Farahmand B.Y., et al. Risk factors for sudden unexpected death in epilepsy: A case-control study. Lancet 1999, 353:888-893.
333. Norremolle A., Riess O., et al. Trinucleotide repeat elongation in the Huntingtin gene in Huntington disease patients from 71 Danish families. Hum. Mol. Genet 1993, 2:1475-1476.
334. Novembre F.J., De Rosayro J., et al. Isolation and characterization of a neuropathogenic simian immunodeficiency virus derived from a sooty mangabey. J. Virol 1998, 72:8841-8851.
335. O'Donnell K.A., Rapp P.R., et al. Preservation of prefrontal cortical volume in behaviorally characterized aged macaque monkeys. Exp. Neurol 1999, 160:300-310.
336. O'Donnell L.A., Agrawal A., et al. Human immunodeficiency virus (HIV)-induced neurotoxicity: Roles for the NMDA receptor subtypes. J. Neurosci 2006, 26:981-990.
337. O'Neil S.P., Suwyn C., et al. Correlation of acute humoral response with brain virus burden and survival time in pig-tailed macaques infected with the neurovirulent simian immunodeficiency virus SIVsmmFGb. Am. J. Pathol 2004, 164:1157-1172.
338. Ohsawa K., Black D.H., et al. Detection of a unique genotype of monkey B virus (Cercopithecine herpesvirus 1) indigenous to native Japanese macaques (Macaca fuscata). Comp. Med 2002, 52:555-559.
339. Oikawa, N., Kimura, N., et al. Alzheimer-type tau pathology in advanced aged nonhuman primate brains harboring substantial amyloid deposition. Brain Res., 1315, 137-49.
340. Okabayashi S., Uchida K., et al. Periventricular leucomalacia (PVL)-like lesions in two neonatal cynomolgus monkeys (Macaca fascicularis). J. Comp. Pathol 2010.
341. Okada S., Okeda R. Pathology of radiation myelopathy. Neuropathology 2001, 21:247-265.
342. Oliveira J.M., Chen S., et al. Mitochondrial-dependent Ca2+ handling in Huntington's disease striatal cells: Effect of histone deacetylase inhibitors. J. Neurosci 2006, 26:11174-11186.
343. Ovadia A., Zhang Z., et al. Increased susceptibility to MPTP toxicity in middle-aged rhesus monkeys. Neurobiol. Aging 1995, 16:931-937.
344. Pachner A.R., Amemiya K., et al. Interleukin-6 is expressed at high levels in the CNS in Lyme neuroborreliosis. Neurology 1997, 49:147-152.
345. Pachner A.R., Delaney E., et al. Neuroborreliosis in the nonhuman primate: Borrelia burgdorferi persists in the central nervous system. Ann. Neurol 1995, 38:667-669.
346. Pachner A.R., Delaney E., et al. Inoculation of nonhuman primates with the N40 strain of Borrelia burgdorferi leads to a model of Lyme neuroborreliosis faithful to the human disease. Neurology 1995, 45:165-172.
347. Pachner A.R., Gelderblom H., et al. The rhesus model of Lyme neuroborreliosis. Immunol. Rev 2001, 183:186-204.
348. Pachner A.R., Schaefer H., et al. Pathogenesis of neuroborreliosis-Lessons from a monkey model. Wien. Klin. Wochenschr 1998, 110:870-873.
349. Pachner A.R., Zhang W.F., et al. Detection of active infection in nonhuman primates with Lyme neuroborreliosis: Comparison of PCR, culture, and a bioassay. J. Clin. Microbiol 1998, 36:3243-3247.
350. Page T.L., Einstein M., et al. Morphological alterations in neurons forming corticocortical projections in the neocortex of aged Patas monkeys. Neurosci. Lett 2002, 317:37-41.
351. Palfi S., Brouillet E., et al. Expression of mutated huntingtin fragment in the putamen is sufficient to produce abnormal movement in non-human primates. Mol. Ther 2007, 15:1444-1451.
352. Palmer M.S., Collinge J. Human prion diseases. Curr. Opin. Neurol. Neurosurg 1992, 5:895-901.
353. Parchi P., Capellari S., et al. Typing prion isoforms. Nature 1997, 386:232-234.
354. Parchi P., Zou W., et al. Genetic influence on the structural variations of the abnormal prion protein. Proc. Natl. Acad. Sci. USA 2000, 97:10168-10172.
355. Pendyala G., Trauger S.A., et al. Cerebrospinal fluid proteomics reveals potential pathogenic changes in the brains of SIV-infected monkeys. J. Proteome. Res 2009, 8:2253-2260.
356. Persidsky Y., Limoges J., et al. Reduction in glial immunity and neuropathology by a PAF antagonist and an MMP and TNFalpha inhibitor in SCID mice with HIV-1 encephalitis. J. Neuroimmunol 2001, 114:57-68.
357. Peters A. A fourth type of neuroglial cell in the adult central nervous system. J. Neurocytol 2004, 33:345-357.
358. Peters A., Morrison J.H., et al. Feature article: Are neurons lost from the primate cerebral cortex during normal aging?. Cereb. Cortex 1998, 8:295-300.
359. Peters A., Rosene D.L. In aging, is it gray or white?. J. Comp. Neurol 2003, 462:139-143.
360. Peters A., Rosene D.L., et al. Neurobiological bases of age-related cognitive decline in the rhesus monkey. J. Neuropathol. Exp. Neurol 1996, 55:861-874.
361. Peters A., Sethares C. Is there remyelination during aging of the primate central nervous system?. J. Comp. Neurol 2003, 460:238-254.
362. Peters A., Sethares C., et al. Effects of age on the thickness of myelin sheaths in monkey primary visual cortex. J. Comp. Neurol 2001, 435:241-248.
363. Peters A., Sethares C., et al. Synapses are lost during aging in the primate prefrontal cortex. Neuroscience 2008, 152:970-981.
364. Peters A., Sethares C., et al. The effects of aging on layer 1 in area 46 of prefrontal cortex in the rhesus monkey. Cereb. Cortex 1998, 8:671-684.
365. Peters A., Verderosa A., et al. The neuroglial population in the primary visual cortex of the aging rhesus monkey. Glia 2008, 56:1151-1161.
366. Peterson P.E., Short J.J., et al. Frequency of spontaneous congenital defects in rhesus and cynomolgus macaques. J. Med. Primatol 1997, 26:267-275.
367. Philipp M.T., Aydintug M.K., et al. Early and early disseminated phases of Lyme disease in the rhesus monkey: A model for infection in humans. Infect. Immun 1993, 61:3047-3059.
368. Phipps A.J., Premanandan C., et al. Rabbit and nonhuman primate models of toxin-targeting human anthrax vaccines. Microbiol. Mol. Biol. Rev 2004, 68:617-629.
369. Pisharath H.R., Cooper T.K., et al. Septicemia and peritonitis in a colony of common marmosets (Callithrix jacchus) secondary to Klebsiella pneumoniae infection. Contemp. Top. Lab. Anim. Sci 2005, 44:35-37.
370. Pocchiari M., Puopolo M., et al. Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain 2004, 127:2348-2359.
371. Pomeroy I.M., Jordan E.K., et al. Diffuse cortical atrophy in a marmoset model of multiple sclerosis. Neurosci. Lett 2008, 437:121-124.
372. Potkay S. Diseases of the Callitrichidae: A review. J. Med. Primatol 1992, 21:189-236.
373. Price R.E., Tinkey P.T., et al. Glioblastoma multiforme arising in the irradiated spinal cord of a rhesus monkey (Macaca mulatta). J. Med. Primatol 1996, 25:140-145.
374. Prospero-Garcia O., Gold L.H., et al. Microglia-passaged simian immunodeficiency virus induces neurophysiological abnormalities in monkeys. Proc. Natl. Acad. Sci. USA 1996, 93:14158-14163.
375. Prusiner S.B. Novel proteinaceous infectious particles cause scrapie. Science 1982, 216:136-144.
376. Prusiner S.B. Research on scrapie. Lancet 1982, 2:494-495.
377. Przedborski S., Jackson-Lewis V., et al. The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): A technical review of its utility and safety. J. Neurochem 2001, 76:1265-1274.
378. Pulliam L., Herndier B.G., et al. Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains. J. Clin. Invest 1991, 87:503-512.
379. Ramagopalan S.V., Knight J.C., et al. Multiple sclerosis and the major histocompatibility complex. Curr. Opin. Neurol 2009, 22:219-225.
380. Ramirez-Avila L., Slome S., et al. Eosinophilic meningitis due to Angiostrongylus and Gnathostoma species. Clin. Infect. Dis 2009, 48:322-327.
381. Rao P., Jiang H., et al. Cloning of the rhesus lymphocryptovirus viral capsid antigen and Epstein-Barr virus-encoded small RNA homologues and use in diagnosis of acute and persistent infections. J. Clin. Microbiol 2000, 38:3219-3225.
382. Ratai E.M., Bombardier J.P., et al. Proton magnetic resonance spectroscopy reveals neuroprotection by oral minocycline in a nonhuman primate model of accelerated NeuroAIDS. PLoS One 2010, 5:e10523.
383. Ratai E.M., Pilkenton S.J., et al. In vivo proton magnetic resonance spectroscopy reveals region specific metabolic responses to SIV infection in the macaque brain. BMC Neurosci 2009, 10:63.
384. Ratterree M.S., da Rosa A.P., et al. West Nile virus infection in nonhuman primate breeding colony, concurrent with human epidemic, southern Louisiana. Emerg. Infect. Dis 2003, 9:1388-1394.
385. Ratterree M.S., Didier P.J., et al. Vitamin C deficiency in captive nonhuman primates fed commercial primate diet. Lab. Anim. Sci 1990, 40:165-168.
386. Ratterree M.S., Gutierrez R.A., et al. Experimental infection of rhesus macaques with West Nile virus: Level and duration of viremia and kinetics of the antibody response after infection. J. Infect. Dis 2004, 189:669-676.
387. Rawlins R.G., Kessler M.J. Congenital and hereditary anomalies in the rhesus monkeys (Macaca mulatta) of Cayo Santiago. Teratology 1983, 28:169-174.
388. Reddy P.H., Beal M.F. Amyloid beta, mitochondrial dysfunction and synaptic damage: Implications for cognitive decline in aging and Alzheimer's disease. Trends Mol. Med 2008, 14:45-53.
389. Reddy P.H., Mao P., et al. Mitochondrial structural and functional dynamics in Huntington's disease. Brain Res. Rev 2009, 61:33-48.
390. Redmond D.E., Vinuela A., et al. Influence of cell preparation and target location on the behavioral recovery after striatal transplantation of fetal dopaminergic neurons in a primate model of Parkinson's disease. Neurobiol. Dis 2008, 29:103-116.
391. Reetz J., Wiedemann M., et al. Disseminated lethal Encephalitozoon cuniculi (genotype III) infections in cotton-top tamarins (Oedipomidas oedipus)-A case report. Parasitol. Int 2004, 53:29-34.
392. Remick A.K., Van Wettere A.J., et al. Neoplasia in prosimians: Case series from a captive prosimian population and literature review. Vet. Pathol 2009, 46:746-772.
393. Remick A.K., Wood C.E., et al. Histologic and immunohistochemical characterization of spontaneous pituitary adenomas in fourteen cynomolgus macaques (Macaca fascicularis). Vet. Pathol 2006, 43:484-493.
394. Rezikyan S., Kaaya E.E., et al. B-cell lymphomagenesis in SIV-immunosuppressed cynomolgus monkeys. Int. J. Cancer 1995, 61:574-579.
395. Rideout B.A., Gardiner C.H., et al. Fatal infections with Balamuthia mandrillaris (a free-living amoeba) in gorillas and other Old World primates. Vet. Pathol 1997, 34:15-22.
396. Ringler D.J., Hunt R.D., et al. Simian immunodeficiency virus-induced meningoencephalitis: Natural history and retrospective study. Ann. Neurol 1988, 23(Suppl):S101-S107.
397. Rivadeneira E.D., Ferrari M.G., et al. A novel Epstein-Barr virus-like virus, HV(MNE), in a Macaca nemestrina with mycosis fungoides. Blood 1999, 94:2090-2101.
398. Rivailler P., Cho Y.G., et al. Complete genomic sequence of an Epstein-Barr virus-related herpesvirus naturally infecting a new world primate: A defining point in the evolution of oncogenic lymphocryptoviruses. J. Virol 2002, 76:12055-12068.
399. Rivailler P., Jiang H., et al. Complete nucleotide sequence of the rhesus lymphocryptovirus: Genetic validation for an Epstein-Barr virus animal model. J. Virol 2002, 76:421-426.
400. Rivas K., Garcia A., et al. Methicillin-resistant Staphylococcus aureus (MRSA) pneumonia in a rhesus macaque. J. Am. Assoc. Lab. Anim. Sci 2007, 46.
401. Rivera W.L., Kanbara H. Detection of Entamoeba dispar DNA in macaque feces by polymerase chain reaction. Parasitol. Res 1999, 85:493-495.
402. Roberts E.D., Bohm R.P., et al. Pathogenesis of Lyme neuroborreliosis in the rhesus monkey: The early disseminated and chronic phases of disease in the peripheral nervous system. J. Infect. Dis 1998, 178:722-732.
403. Roitberg B., Khan N., et al. Chronic ischemic stroke model in cynomolgus monkeys: Behavioral, neuroimaging and anatomical study. Neurol. Res 2003, 25:68-78.
404. Rubinsztein D.C., Barton D.E., et al. Analysis of the huntingtin gene reveals a trinucleotide-length polymorphism in the region of the gene that contains two CCG-rich stretches and a correlation between decreased age of onset of Huntington's disease and CAG repeat number. Hum. Mol. Genet 1993, 2:1713-1715.
405. Ryan L.A., Cotter R.L., et al. Macrophages, chemokines and neuronal injury in HIV-1-associated dementia. Cell Mol. Biol. (Noisy-le-grand) 2002, 48:137-150.
406. Sakakibara I., Sugimoto Y., et al. Natural transmission of Entamoeba histolytica from mother cynomolgus monkeys (Macaca fascicularis) to their newborn infants under indoor rearing conditions. Jikken Dobutsu 1982, 31:135-138.
407. Salaria S., Badkoobehi H., et al. Toll-like receptor pathway gene expression is associated with human immunodeficiency virus-associated neurodegeneration. J. Neurovirol 2007, 13:496-503.
408. Samuel B.U., Ponnuraj E., et al. Experimental poliomyelitis in bonnet monkey. Clinical features, virology and pathology. Dev. Biol. Stand 1993, 78:71-78.
409. Sandell J.H., Peters A. Effects of age on nerve fibers in the rhesus monkey optic nerve. J. Comp. Neurol 2001, 429:541-553.
410. Sandell J.H., Peters A. Disrupted myelin and axon loss in the anterior commissure of the aged rhesus monkey. J. Comp. Neurol 2003, 466:14-30.
411. Sasseville V.G., Lane J.H., et al. VCAM-1 expression and leukocyte trafficking to the CNS occur early in infection with pathogenic isolates of SIV. J. Med. Primatol 1995, 24:123-131.
412. Sasseville V.G., Mansfield K.G. Overview of known non-human primate pathogens with potential to affect colonies used for toxicity testing. J. Immunotoxicol 2010, 7:79-92.
413. Sasseville V.G., Pauley D.R., et al. Concurrent central nervous system toxoplasmosis and simian immunodeficiency virus-induced AIDS encephalomyelitis in a Barbary macaque (Macaca sylvana). Vet. Pathol 1995, 32:81-83.
414. Sauer R.M., Zook B.C., et al. Demyelinating encephalomyelopathy associated with lead poisoning in nonhuman primates. Science 1970, 169:1091-1093.
415. Scheibel M.E., Lindsay R.D., et al. Progressive dendritic changes in aging human cortex. Exp. Neurol 1975, 47:392-403.
416. Scheifele D.W., Daum R.S., et al. Haemophilus influenzae bacteremia and meningitis in infant primates. J. Lab. Clin. Med 1980, 95:450-462.
417. Schielke J.E., Kiem H.P., et al. Radiation-induced glioblastoma multiforme in two adult baboons (Papio cynocephalus anubis). Comp. Med 2004, 54:327-332.
418. Schifitto G., Peterson D.R., et al. Valproic acid adjunctive therapy for HIV-associated cognitive impairment: A first report. Neurology 2006, 66:919-921.
419. Schifitto G., Zhong J., et al. Lithium therapy for human immunodeficiency virus type 1-associated neurocognitive impairment. J. Neurovirol 2009, 15:176-186.
420. Schmidlin E., Jouffrais C., et al. A case of polymicrogyria in macaque monkey: Impact on anatomy and function of the motor system. BMC Neurosci 2009, 10:155.
421. Schmitz J.E., Kuroda M.J., et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 1999, 283:857-860.
422. Schmitz J.E., Simon M.A., et al. A nonhuman primate model for the selective elimination of CD8+ lymphocytes using a mouse-human chimeric monoclonal antibody. Am. J. Pathol 1999, 154:1923-1932.
423. Schultheiss T.E. Spinal cord radiation "tolerance": doctrine versus data. Int. J. Radiat. Oncol. Biol. Phys 1990, 19:219-221.
424. Schultheiss T.E. Spinal cord radiation tolerance. Int. J. Radiat. Oncol. Biol. Phys 1994, 30:735-736.
425. Schultheiss T.E., Cohen L., et al. Normal tissue reactions and complications following high-energy neutron beam therapy. II: Complication rates adjusted for censoring. Int. J. Radiat. Oncol. Biol. Phys 1990, 18:165-171.
426. Schultheiss T.E., Stephens L.C., et al. Neutron RBE for primate spinal cord treated with clinical regimens. Radiat. Res 1992, 129:212-217.
427. Schultheiss T.E., Stephens L.C., et al. Volume effects in rhesus monkey spinal cord. Int. J. Radiat. Oncol. Biol. Phys 1994, 29:67-72.
428. Schuster F.L., Visvesvara G.S. Free-living amoebae as opportunistic and non-opportunistic pathogens of humans and animals. Int. J. Parasitol 2004, 34:1001-1027.
429. Sebire G., Tabarki B., et al. Cerebral venous sinus thrombosis in children: Risk factors, presentation, diagnosis and outcome. Brain 2005, 128:477-489.
430. Sheffield L.G., Berman N.E. Microglial expression of MHC class II increases in normal aging of nonhuman primates. Neurobiol. Aging 1998, 19:47-55.
431. Sheffield W.D., Squire R.A., et al. Cerebral venous thrombosis in the rhesus monkey. Vet. Pathol 1981, 18:326-334.
432. Simon M.A. Polyomaviruses of nonhuman primates: Implications for research. Comp. Med 2008, 58:51-56.
433. Simon M.A. Simian parvoviruses: Biology and implications for research. Comp. Med 2008, 58:47-50.
434. Simon M.A., Daniel M.D., et al. Disseminated B virus infection in a cynomolgus monkey. Lab. Anim. Sci 1993, 43:545-550.
435. Simon M.A., Ilyinskii P.O., et al. Association of simian virus 40 with a central nervous system lesion distinct from progressive multifocal leukoencephalopathy in macaques with AIDS. Am. J. Pathol 1999, 154:437-446.
436. Simon-Sanchez J., Schulte C., et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat. Genet 2009, 41:1308-1312.
437. Slierendregt B.L., Hall M., et al. Identification of an Mhc-DPB1 allele involved in susceptibility to experimental autoimmune encephalomyelitis in rhesus macaques. Int. Immunol 1995, 7:1671-1679.
438. Sloane J.A., Hollander W., et al. Increased microglial activation and protein nitration in white matter of the aging monkey. Neurobiol. Aging 1999, 20:395-405.
439. Sly D.L., Toft J.D., et al. Spontaneous occurrence of Angiostrongylus costaricensis in marmosets (Saguinus mystax). Lab. Anim. Sci 1982, 32:286-288.
440. Smith D.R., Calacsan C., et al. Succimer and the urinary excretion of essential elements in a primate model of childhood lead exposure. Toxicol. Sci 2000, 54:473-480.
441. Smith D.R., Woolard D., et al. Succimer and the reduction of tissue lead in juvenile monkeys. Toxicol. Appl. Pharmacol 2000, 166:230-240.
442. Smith M.A., Takeuchi K., et al. Dose-response model for Listeria monocytogenes-induced stillbirths in nonhuman primates. Infect. Immun 2008, 76:726-731.
443. Smith M.A., Takeuchi K., et al. Nonhuman primate model for Listeria monocytogenes-induced stillbirths. Infect. Immun 2003, 71:1574-1579.
444. Smith M.O., Lackner A.A. Effects of sex, age, puncture site, and blood contamination on the clinical chemistry of cerebrospinal fluid in rhesus macaques (Macaca mulatta). Am. J. Vet. Res 1993, 54:1845-1850.
445. Soderstrom K., O'Malley J., et al. Neural repair strategies for Parkinson's disease: Insights from primate models. Cell Transplant 2006, 15:251-265.
446. Solleveld H.A., van Zwieten M.J., et al. Clinicopathologic study of six cases of meningitis and meningoencephalitis in chimpanzees (Pan troglodytes). Lab. Anim. Sci 1984, 34:86-90.
447. Spitzenberger T.J., Heilman D., et al. Novel delivery system enhances efficacy of antiretroviral therapy in animal model for HIV-1 encephalitis. J. Cereb. Blood Flow Metab 2007, 27:1033-1042.
448. Steele M.D., Giddens W.E., et al. Spontaneous paramyxoviral encephalitis in nonhuman primates (Macaca mulatta and M. nemestrina). Vet. Pathol 1982, 19:132-139.
449. Stephens L.C., Hussey D.H., et al. Late effects of 50 MeV d leads to Be neutron and cobalt-60 irradiation of rhesus monkey cervical spinal cord. Int. J. Radiat. Oncol. Biol. Phys 1983, 9:859-864.
450. Subramaniam S., Sixt K.M., et al. Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity. Science 2009, 324:1327-1330.
451. Suleman M.A., Johnson B.J., et al. An outbreak of poliomyelitis caused by poliovirus type I in captive black and white colobus monkeys (Colobus abyssinicus kikuyuensis) in Kenya. Trans. R. Soc. Trop. Med. Hyg 1984, 78:665-669.
452. Suzuki T., Maruno M., et al. Genetic analysis of human glioblastomas using a genomic microarray system. Brain Tumor. Pathol 2004, 21:27-34.
453. Sweet B.H., Hilleman M.R. The vacuolating virus, S.V. 40. Proc. Soc. Exp. Biol. Med 1960, 105:420-427.
454. Szabo C.A., Knape K.D., et al. Mortality in captive baboons with seizures: A new model for SUDEP?. Epilepsia 2009, 50:1995-1998.
455. Szabo C.A., Leland M.M., et al. Clinical and EEG phenotypes of epilepsy in the baboon (Papio hamadryas spp.). Epilepsy Res 2005, 65:71-80.
456. Szabo C.A., Leland M.M., et al. Scalp EEG for the diagnosis of epilepsy and photosensitivity in the baboon. Am. J. Primatol 2004, 62:95-106.
457. 't Hart B.A., Massacesi L. Clinical, pathological, and immunologic aspects of the multiple sclerosis model in common marmosets (Callithrix jacchus). J. Neuropathol. Exp. Neurol 2009, 68:341-355.
458. 't Hart B.A., Vogels J., et al. Non-invasive measurement of brain damage in a primate model of multiple sclerosis. Trends Mol. Med 2004, 10:85-91.
459. Tachibana H., Cheng X.J., et al. High prevalence of infection with Entamoeba dispar, but not E. histolytica, in captive macaques. Parasitol. Res 2001, 87:14-17.
460. Taffe M.A., Kotzebue R.W., et al. Long-lasting reduction in hippocampal neurogenesis by alcohol consumption in adolescent nonhuman primates. Proc. Natl. Acad. Sci. USA 2010, 107:11104-11109.
461. Tarantal A.F., Otiang-a-Owiti G., et al. Holoprosencephaly in a long-tailed macaque (Macaca fascicularis): A case report. J. Med. Primatol 1994, 23:319-324.
462. Tarantal A.F., Salamat M.S., et al. Neuropathogenesis induced by rhesus cytomegalovirus in fetal rhesus monkeys (Macaca mulatta). J. Infect. Dis 1998, 177:446-450.
463. Tate C.L., Lewis J.C., et al. Herpesvirus T as the cause of encephalitis in an owl monkey (Aotus trivirgatus). Lab. Anim. Sci 1971, 21:743-745.
464. Thompson S.A., Hilliard J.K., et al. Retrospective analysis of an outbreak of B virus infection in a colony of DeBrazza's monkeys (Cercopithecus neglectus). Comp. Med 2000, 50:649-657.
465. Toggas S.M., Masliah E., et al. Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine. Brain Res 1996, 706:303-307.
466. Trindade G.F., Marchevsky R.S., et al. Limited replication of yellow fever 17DD and 17D-Dengue recombinant viruses in rhesus monkeys. An Acad. Bras. Cienc 2008, 80:311-321.
467. Tryggestad E., Christian M., et al. Inter- and intrafraction patient positioning uncertainties for intracranial radiotherapy: A study of four frameless, thermoplastic mask-based immobilization strategies using daily cone-beam CT. Int. J. Radiat. Oncol. Biol. Phys 2010, 80:281-290.
468. Tsai T.H., Liu Y.C., et al. An outbreak of meningitis caused by Angiostrongylus cantonensis in Kaohsiung. J. Microbiol. Immunol. Infect 2001, 34:50-56.
469. Twenhafel N.A., Whitehouse C.A., et al. Multisystemic abscesses in African green monkeys (Chlorocebus aethiops) with invasive Klebsiella pneumoniae-Identification of the hypermucoviscosity phenotype. Vet. Pathol 2008, 45:226-231.
470. Tyler I. Herpes simplex type 2 virus: A new horizon. ABNF J 2005, 16:63-64.
471. Tzartos J.S., Friese M.A., et al. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am. J. Pathol 2008, 172:146-155.
472. Uemura E. Age-related changes in prefrontal cortex of Macaca mulatta: Synaptic density. Exp. Neurol 1980, 69:164-172.
473. Valis J.D., Newell N., et al. Characterization of SA12 as a simian virus 40-related papovavirus of chacma baboons. Infect. Immun 1977, 18:247-252.
474. van Dellen A.F., Stewart C.G., et al. Studies of encephalitozoonosis in vervet monkeys (Cercopithecus pygerythrus) orally inoculated with spores of Encephalitozoon cuniculi isolated from dogs (Canis familiaris). Onderstepoort J. Vet. Res 1989, 56:1-22.
475. Van Lambalgen R., Jonker M. Experimental allergic encephalomyelitis in rhesus monkeys: II. Treatment of EAE with anti-T lymphocyte subset monoclonal antibodies. Clin. Exp. Immunol 1987, 68:305-312.
476. Vasconcelos D., Barnewall R., et al. Pathology of inhalation anthrax in cynomolgus monkeys (Macaca fascicularis). Lab. Invest 2003, 83:1201-1209.
477. Venken K., Hellings N., et al. Natural naive CD4+CD25+CD127low regulatory T cell (Treg) development and function are disturbed in multiple sclerosis patients: Recovery of memory Treg homeostasis during disease progression. J. Immunol 2008, 180:6411-6420.
478. Venken K., Hellings N., et al. Disturbed regulatory T cell homeostasis in multiple sclerosis. Trends Mol. Med 2010, 16:58-68.
479. Verstraeten S.V., Aimo L., et al. Aluminium and lead: Molecular mechanisms of brain toxicity. Arch. Toxicol 2008, 82:789-802.
480. Vetesi F., Balsai A., et al. Proceedings: Abortion in Gray's monkey (Cercopithecus mona) associated with Listeria monocytogenes. Acta. Microbiol. Acad. Sci. Hung 1972, 19:441-443.
481. Viglietta V., Baecher-Allan C., et al. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J. Exp. Med 2004, 199:971-979.
482. Villoslada P., Abel K., et al. Frequency, heterogeneity and encephalitogenicity of T cells specific for myelin oligodendrocyte glycoprotein in naive outbred primates. Eur J. Immunol 2001, 31:2942-2950.
483. Villoslada P., Hauser S.L., et al. Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system. J. Exp. Med 2000, 191:1799-1806.
484. Visvesvara G.S., Martinez A.J., et al. Leptomyxid ameba, a new agent of amebic meningoencephalitis in humans and animals. J. Clin. Microbiol 1990, 28:2750-2756.
485. Visvesvara G.S., Schuster F.L., et al. Balamuthia mandrillaris, N. G., N. Sp., agent of amebic meningoencephalitis in humans and other animals. J. Eukaryot. Microbiol 1993, 40:504-514.
486. von Bohlen und Halbach O., Schober A., et al. Genes, proteins, and neurotoxins involved in Parkinson's disease. Prog. Neurobiol 2004, 73:151-177.
487. von Budingen H.C., Hauser S.L., et al. Molecular characterization of antibody specificities against myelin/oligodendrocyte glycoprotein in autoimmune demyelination. Proc. Natl. Acad. Sci. USA 2002, 99:8207-8212.
488. Wachtman L.M., Mansfield K.G. Opportunistic infections in immunologically compromised nonhuman primates. ILAR J 2008, 49:191-208.
489. Wadsworth J.D., Collinge J. Update on human prion disease. Biochim. Biophys. Acta 2007, 1772:598-609.
490. Wadsworth J.D., Hill A.F., et al. Molecular and clinical classification of human prion disease. Br. Med. Bull 2003, 66:241-254.
491. Wadsworth J.D., Joiner S., et al. Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice. Proc. Natl. Acad. Sci. USA 2008, 105:3885-3890.
492. Walker F.O. Huntington's disease. Lancet 2007, 369:218-228.
493. Walker L.C., Masters C., et al. Amyloid in the brains of aged squirrel monkeys. Acta. Neuropathol 1990, 80:381-387.
494. Wang Y., White M.G., et al. Activation of cyclin-dependent kinase 5 by calpains contributes to human immunodeficiency virus-induced neurotoxicity. J. Neurochem 2007, 103:439-455.
495. Weed M.R., Hienz R.D., et al. Central nervous system correlates of behavioral deficits following simian immunodeficiency virus infection. J. Neurovirol 2003, 9:452-464.
496. Weimer M.B., Gutierrez A., et al. Serial electrophysiologic studies in rhesus monkeys with Krabbe disease. Muscle Nerve 2005, 32:185-190.
497. Weissmann C. The state of the prion. Nat. Rev. Microbiol 2004, 2:861-871.
498. Wenzel H.J., Woolley C.S., et al. Kainic acid-induced mossy fiber sprouting and synapse formation in the dentate gyrus of rats. Hippocampus 2000, 10:244-260.
499. Werner H., Janitschke K., et al. Observations on marmoset monkeys of the species Saguinus (Oedipomidas) oedipus following oral and intraperitoneal infection by different cyst-forming Toxoplasma strains of varying virulence. I. Clinical, pathological anatomical and parasitological findings. Zentralbl. Bakteriol. Orig 1969, 209:553-569.
500. Westmoreland S.V., Halpern E., et al. Simian immunodeficiency virus encephalitis in rhesus macaques is associated with rapid disease progression. J. Neurovirol 1998, 4:260-268.
501. Westmoreland S.V., Rosen J., et al. Necrotizing meningoencephalitis and pneumonitis in a simian immunodeficiency virus-infected rhesus macaque due to Acanthamoeba. Vet. Pathol 2004, 41:398-404.
502. Wiley C.A., Achim C.L., et al. HIV mediates a productive infection of the brain. AIDS 1999, 13:2055-2059.
503. Wiley C.A., Masliah E., et al. Measurement of CNS HIV burden and its association with neurologic damage. Adv. Neuroimmunol 1994, 4:319-325.
504. Wiley C.A., Masliah E., et al. Neocortical damage during HIV infection. Ann. Neurol 1991, 29:651-657.
505. Wilkinson L.M., Wallace J.M., et al. Disseminated blastomycosis in a rhesus monkey (Macaca mulatta). Vet. Pathol 1999, 36:460-462.
506. Williams K., Westmoreland S., et al. Magnetic resonance spectroscopy reveals that activated monocytes contribute to neuronal injury in SIV neuroAIDS. J. Clin. Invest 2005, 115:2534-2545.
507. Williams R., Bokhari S., et al. Nonhuman primate models of NeuroAIDS. J. Neurovirol 2008, 14:292-300.
508. Willy M.E., Woodward R.A., et al. Management of a measles outbreak among Old World nonhuman primates. Lab. Anim. Sci 1999, 49:42-48.
509. Wilson J.G., Gavan J.A. Congenital malformations in nonhuman primates: Spontaneous and experimentally induced. Anat. Rec 1967, 158:99-109.
510. Wisco J.J., Killiany R.J., et al. An MRI study of age-related white and gray matter volume changes in the rhesus monkey. Neurobiol. Aging 2008, 29:1563-1575.
511. Wisniewski H.M., Ghetti B., et al. Neuritic (senile) plaques and filamentous changes in aged rhesus monkeys. J. Neuropathol. Exp. Neurol 1973, 32:566-584.
512. Wong K.T., Shieh W.J., et al. Nipah virus infection: Pathology and pathogenesis of an emerging paramyxoviral zoonosis. Am. J. Pathol 2002, 161:2153-2167.
513. Wong M.M., Karr S.L., et al. Experimental infections with pathogenic free-living amebae in laboratory primate hosts: I. (B) A study on susceptibility to Acanthamoeba culbertsoni. J. Parasitol 1975, 61:682-690.
514. Wong M.M., Kozek W.J. Spontaneous toxoplasmosis in macaques: A report of four cases. Lab. Anim. Sci 1974, 24:273-278.
515. Wu J., Li Q., et al. Evaluation of Dimebon in cellular model of Huntington's disease. Mol. Neurodegener 2008, 3:15.
516. Wyss-Coray T., Masliah E., et al. Dysregulation of signal transduction pathways as a potential mechanism of nervous system alterations in HIV-1 gp120 transgenic mice and humans with HIV-1 encephalitis. J. Clin. Invest 1996, 97:789-798.
517. Xu J., Yan H.C., et al. Effects of lead exposure on hippocampal metabotropic glutamate receptor subtype 3 and 7 in developmental rats. J. Negat. Results Biomed 2009, 8:5.
518. Yamano K., Kanetoshi A., et al. Japanese monkey (Macaca fuscata) with alveolar echinococcosis after treatment with albendazole for 10 years: Serodiagnosis and determination of albendazole metabolites. Parasitol. Res 2009, 106:69-74.
519. Yang S.H., Cheng P.H., et al. Towards a transgenic model of Huntington's disease in a non-human primate. Nature 2008, 453:921-924.
520. Yearley J.H., Xia D., et al. Interleukin-18 predicts atherosclerosis progression in SIV-infected and uninfected rhesus monkeys (Macaca mulatta) on a high-fat/high-cholesterol diet. Lab. Invest 2009, 89:657-667.
521. Young A.R., Touzani O., et al. Early reperfusion in the anesthetized baboon reduces brain damage following middle cerebral artery occlusion: A quantitative analysis of infarction volume. Stroke 1997, 28:632-637. discussion 637-638.
522. Zdziarski J.M., Sarich N.A., et al. Molecular analysis of SV-40-CAL, a new slow growing SV-40 strain from the kidney of a caged New World monkey with fatal renal disease. Virus Genes 2004, 29:183-190.
523. Zeman D.H., Baskin G.B. Encephalitozoonosis in squirrel monkeys (Saimiri sciureus). Vet. Pathol 1985, 22:24-31.
524. Zhou Y., Takahashi E., et al. Interactions between the NR2B receptor and CaMKII modulate synaptic plasticity and spatial learning. J. Neurosci 2007, 27:13843-13853.
525. Zink M.C., Amedee A.M., et al. Pathogenesis of SIV encephalitis. Selection and replication of neurovirulent SIV. Am. J. Pathol 1997, 151:793-803.
526. Zink M.C., Clements J.E. A novel simian immunodeficiency virus model that provides insight into mechanisms of human immunodeficiency virus central nervous system disease. J. Neurovirol 2002, 8(Suppl. 2):42-48.
527. Zink M.C., Coleman G.D., et al. Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis. J. Infect. Dis 2001, 184:1015-1021.
528. Zink M.C., Suryanarayana K., et al. High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency virus encephalitis. J. Virol 1999, 73:10480-10488.
529. Zink M.C., Uhrlaub J., et al. Neuroprotective and anti-human immunodeficiency virus activity of minocycline. JAMA 2005, 293:2003-2011.
530. Zook B.C., Sauer R.M. Leucoencephalomyelosis in nonhuman primates associated with lead poisoning. J. Wildl. Dis 1973, 9:61-63.
531. Zook B.C., Sauer R.M., et al. Lead poisoning in zoo-dwelling primates. Am. J. Phys. Anthropol 1973, 38:415-423.
532. zur Hausen H., Gissmann L. Lymphotropic papovaviruses isolated from African green monkey and human cells. Med. Microbiol. Immunol 1979, 167:137-153.